SynPhNe key facts
as of Oct 2026- Developer of a wearable connected health system designed to help people train their brain and body.
- SynPhNe is valued at approximately $37.2M as of Oct 2026 (last reported valuation).
- It has raised $16.0M; the latest was Later Stage VC in Apr 2025.
- Notable investors include UCEA Capital Partners, Event Horizon Capital, Isay Yutkevich, NTUitive, Ravinder Kichloo.
- Status: Privately Held (backing).
SynPhNe's last reported valuation, Mar 2024. Nothing priced has surfaced since.
- ·Watch SynPhNe: the Monday email on marks, rounds and moves
SynPhNe funding rounds
No funding rounds for SynPhNe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
SynPhNe valuation
SynPhNe's last reported valuation was $37.2 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.
SynPhNe investors
5 investors are on record for SynPhNe, including UCEA Capital Partners, Event Horizon Capital, Isay Yutkevich and NTUitive.
About SynPhNe
Developer of a wearable connected health system designed to help people train their brain and body. The company's system consists of an arm and headgear that senses muscle and brain signals that communicate wirelessly with computer software that trains the user in how to manage conscious and unconscious responses and leverage the ability of the brain to rewire itself, enabling the healthcare industry to treat strokes, cerebral palsy, traumatic brain injury, dyslexia, early dementia, and stress disorders.
- Sector
- Healthcare
- HQ
- Somerville, NJ, United States
- Founded
- 2013
- Employees
- 18
- Website
- synphne.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.